The Fraudulent Industry Studies
Prior to COVID-19, not a single study had provided evidence against the use of HCQ based on safety concerns. In response to the mounting tsunami that HCQ was safe and effective against COVID, Gates, Dr. Fauci and their Pharma allies deployed an army of industry-linked researchers to gin up contrived evidence of its dangers. By 2020, we shall see, Bill Gates exercised firm control over WHO and
deployed the agency in his effort to discredit HCQ.
Dr. Fauci, Bill Gates, and the WHO allegedly financed a series of fraudulent studies aimed at discrediting hydroxychloroquine (HCQ) as unsafe. These studies administered dangerously high doses, beginning with 2,400 mg on the first day, rather than the standard 400 mg/day, resulting in increased mortality among elderly patients. The trials, such as the UK’s Recovery and the UN’s Solidarity studies, were criticized for intentionally pushing toxic HCQ dosing to “prove” its dangers. Key figures, including Peter Horby, faced no repercussions despite the risks to patients, while Gates’ involvement was highlighted as a driving force behind the lethal protocols. WHO meetings established these extreme dosing regimens without proper validation, ultimately contributing to the mischaracterization of HCQ’s effectiveness by the FDA.
The March 13, 2020 meeting minutes indicate that BMGF understood the correct drug dosing and the importance of early administration. However, researchers provided potentially lethal doses without considering patient weight and missed critical treatment windows. The Solidarity trial deviated from standard protocols, gathering only mortality data and not tracking in-hospital complications, which shielded WHO from accountability for adverse reactions. Furthermore, consent forms for the elderly patients receiving high doses were either missing or questionable, with claims of “retrospective” consent that raise ethical concerns. A Brazilian study using a high dose of chloroquine resulted in 39% mortality among participants, revealing toxicity without intervention from WHO or trial coordinators to adjust dosing. Moreover, while Gates may not have directly funded the troubling JAMA study, connections exist through funding patterns to researchers involved. The studies backed by Gates omitted crucial components of HCQ treatment, thus emphasizing its perceived danger and ineffectiveness.
Recent Comments